-
I-Crisaborole
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Crisaborole I-Atopic Dermatitis kanye ne-Eczema I-Pfizer -
I-Etelcacetide
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Etelcacetide I-hyperparathyroidism yesibili (HPT) Amgen -
Abemaciclib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) Abemaciclib Umdlavuza webele, ukwelashwa komdlavuza wendlala yesinye Eli Lily Dec.15,2029 -
I-Deucracitinib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Deucracitinib I-Anti plaque psoriasis Inkampani yaseBristol-Myers Squibb Nov.07,2033 -
I-Apremilast
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Apremilast i-psoriatic arthritis Celgene -
I-Remdesivir
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Remdesivir Ama-Antivirus (Ebola, Covid-19) IGileyadi -
I-Paxlovid
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Paxlovid I-COVID-19 I-Pfizer -
I-Pomalidomide
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Pomalidomide Umuthi we-Oncology Celgene -
I-Nirmatrelvir
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Nirmatrelvir I-3C-Like Protease (3CLPRO) Inhibitor Kanye ne-SARS-Cov-2 Mpro Inhibitor -
I-Eltrombopag
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Eltrombopag I-ITP ne-Aplastic anemia I-Novartis ne-GSK Meyi. 20, 2023 -
I-Ruxolitinib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Ruxolitinib I-Myelofibrosis Novartis Julayi 6, 2024 -
I-Crisaborole
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Crisaborole I-Atopic Dermatitis kanye ne-Eczema I-Pfizer Juni 11, 2026